Lisa A. Carey, MD, and Ann Partridge, MD, MPH, Appointed Co-Chairs of the Alliance for Clinical Trials in Oncology Breast Committee
Lisa A. Carey, MD
Ann Partridge, MD, MPH
Lisa A. Carey, MD, of the University of North Carolina (UNC), and Ann Partridge, MD, MPH, of Dana-Farber Cancer Institute, have been appointed Co-Chairs of the Alliance for Clinical Trials in Oncology Breast Committee.
The Alliance for Clinical Trials in Oncology develops and conducts cancer clinical trials, develops optimal treatment and prevention strategies for cancer, and researches methods to alleviate side effects of cancer and cancer treatments. The organization is a member of the National Cancer Institute’s (NCI’s) National Clinical Trials Network and consists of nearly 10,000 cancer specialists at hospitals, medical centers, and community clinics across North America.
Drs. Carey and Partridge will oversee the committee’s work, which focuses on breast cancer clinical research. The committee is responsible for developing new trials; ensuring each project’s scientific excellence, operational efficiency, and productivity; as well as promoting collaboration with other NCI-funded clinical trials groups.
Dr. Carey is Physician-in-Chief of the North Carolina Cancer Hospital and Chief of Hematology/Oncology as well as the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research in the UNC School of Medicine. She is Medical Director of the UNC Breast Cancer and a member of the UNC Lineberger Comprehensive Cancer Center.
Dr. Partridge is the Founder and Director of the Program for Young Women with Breast Cancer, the Director of the Adult Survivorship Program, and a senior physician at Dana-Farber. She is also Associate Professor of Medicine at Harvard Medical School. ■